1.Chlorpromazine-induced Exfoliative Photoallergic Reaction
Young Hoon KIM ; Gwang Bog LEE
Journal of the Korean Society of Biological Therapies in Psychiatry 2020;26(3):269-273
Despite the availability of second-generation antipsychotic drugs, chlorpromazine is still commonly used in Korea and many other countries due to its cost effectiveness, particularly for patients experiencing psychomotor excitement. Adverse effects of chlorpromazine include photosensitivity and phototoxic and photoallergic skin reactions. We present a case of severe photoallergic skin reactions to chlorpromazine that developed 3 days after use of the drug. The skin lesions resolved completely within one week after stopping the drug. A previous history of exposure to chlorpromazine was unknown and the patient had never previously experienced any form of drug-induced photosensitivity. This case highlights the need for awareness of the cutaneous adverse effects of chlorpromazine and the importance of educating patients.
3.Erratum: Correction of the name of society.
Miseon KIM ; Young Han KIM ; Yong Beom KIM ; Jayeon KIM ; Jae Weon KIM ; Mi Hye PARK ; Joo Hyun PARK ; Jeong Ho RHEE ; Myong Cheol LIM ; Joon Seok HONG
Obstetrics & Gynecology Science 2018;61(6):707-707
The name of society was published incorrectly.
4.Fertility preservation during cancer treatment: The Korean Society for Fertility Preservation clinical guidelines.
Jayeon KIM ; Seul Ki KIM ; Kyung Joo HWANG ; Seok Hyun KIM
Clinical and Experimental Reproductive Medicine 2017;44(4):171-174
While many fertility preservation (FP) options now exist for reproductive-aged cancer patients, access to these services continues to be limited. A comprehensive FP program should be organized to serve oncofertility patients effectively. Also, much effort is needed from various individuals—patients, specialists from various fields, and consultants—to facilitate FP in a timely manner. Various challenges still exist in improving access to FP programs. To improve access to FP treatment, it is important to educate oncologists and patients via electronic tools and to actively navigate patients through the system. Reproductive endocrinology practices that receive oncofertility referrals must be equipped to provide a full range of options on short notice. A multidisciplinary team approach is required, involving physicians, nurses, mental health professionals, office staff, and laboratory personnel. The bottom line of FP patient care is to understand the true nature of each patient's specific situation and to develop a patient flow system that will help build a successful FP program. Expanding the patient flow system to all comprehensive cancer centers will ensure that all patients are provided with adequate information regarding their fertility, regardless of geography.
Endocrinology
;
Fertility Preservation*
;
Fertility*
;
Geography
;
Humans
;
Laboratory Personnel
;
Mental Health
;
Patient Care
;
Referral and Consultation
;
Specialization
5.Building a successful fertility preservation program at a major cancer center.
Jayeon KIM ; Kenneth H KIM ; Jennifer E MERSEREAU
Journal of Gynecologic Oncology 2014;25(2):148-154
Over 150,000 reproductive age individuals face fertility-threatening cancer treatments each year. Improved detection and treatment of cancer in reproductive-age patients have greatly increased the long-term survival and made it possible for these individuals to consider their long-term quality-of-life after cancer including having biologic offspring. Various methods of fertility preservation (FP) are now available for both males and females. In order to maximize FP options available to patients facing imminent gonadotoxic therapies, it is crucial that women have quick access to FP care and that providers expedite FP strategies. The overarching goal of a clinical FP program is to help patients and their physicians consider the impact of treatment on future fertility and facilitate FP efforts in what is often a limited time period before cancer treatment begins.
Female
;
Fertility Preservation*
;
Fertility*
;
Humans
;
Male
6.Association between Parity and Blood Pressure in Korean Women: Korean National Health and Nutrition Examination Survey, 2010-2012.
Miae JANG ; Yeonji LEE ; Jiho CHOI ; Beomseok KIM ; Jayeon KANG ; Yongchae KIM ; Sewook CHO
Korean Journal of Family Medicine 2015;36(6):341-348
BACKGROUND: Pregnancy considerably alters cardiovascular dynamics, and thereby affects the transition of blood pressure after delivery in women. We aimed to analyze the association between parity and blood pressure in Korean adult women. METHODS: We included 8,890 women who participated in Korean National Health and Nutrition Examination Survey between 2010 and 2012. We divided the population according to the menopause status and analyzed the association between parity and blood pressure by using multiple regression analysis, and on hypertension, by using logistic regression analysis. RESULTS: Systolic and diastolic blood pressures were significantly associated with parity in premenopausal women (beta=-0.091 [P<0.001] and beta=-0.069 [P<0.001], respectively). In the analysis that excluded women receiving antihypertensive medication, the systolic and diastolic blood pressure of postmenopausal women were significantly associated with parity (beta=-0.059 [P=0.022] and beta=-0.054 [P=0.044], respectively). Parity was found to prevent hypertension after adjustment for confounders in postmenopausal women (odds ratio, 0.55; 95% confidence interval, 0.310-0.985). CONCLUSION: We found that parity prevented hypertension in Korean women.
Adult
;
Blood Pressure*
;
Female
;
Humans
;
Hypertension
;
Logistic Models
;
Menopause
;
Nutrition Surveys*
;
Parity*
;
Pregnancy
7.Relationship between phospholipase C zeta immunoreactivity and DNA fragmentation and oxidation in human sperm.
Ju Hee PARK ; Seul Ki KIM ; Jayeon KIM ; Ji Hee KIM ; Jae Hoon CHANG ; Byung Chul JEE ; Seok Hyun KIM
Obstetrics & Gynecology Science 2015;58(3):232-238
OBJECTIVE: The study aimed to evaluate the feasibility and reproducibility of measuring phospholipase C zeta (PLCzeta) using immunostaining in human sperm and to investigate the relationship between PLCzeta immunoreactivity and DNA fragmentation and oxidation in human sperm. METHODS: Semen samples were obtained from participants (n=44) and processed by the conventional swim-up method. Sperm concentration, motility, normal form by strict morphology, DNA fragmentation index assessed by terminal deoxynucleotidyl transferase dUTP nick end labeling method and immunofluorescent expression for 8-hydroxy-2'-deoxyguanosine (8-OHdG) and PLCzeta were assessed. RESULTS: When duplicate PLCzeta tests were performed on two sperm samples from each of the 44 participants, similar results were obtained (74.1+/-9.4% vs. 75.4+/-9.7%). Two measurements of PLCzeta were found to be highly correlated with each other (r=0.759, P<0.001). Immunoreactivity of PLCzeta was not associated with donor's age, sperm concentration, motility, and the percentage of normal form as well as DNA fragmentation index. However, immunoreactivity of PLCzeta showed a significant negative relationship with 8-OHdG immunoreactivity (r=-0.404, P=0.009). CONCLUSION: Measurement of PLCzeta by immunostaining is feasible and reproducible. Lower expression of PLCzeta in human sperm may be associated with higher sperm DNA oxidation status.
DNA
;
DNA Fragmentation*
;
DNA Nucleotidylexotransferase
;
Humans
;
Semen
;
Spermatozoa*
;
Type C Phospholipases*
8.Embryonic development in human oocytes fertilized by split insemination.
Myo Sun KIM ; Jayeon KIM ; Hye Won YOUM ; Jung Yeon PARK ; Hwa Young CHOI ; Byung Chul JEE
Obstetrics & Gynecology Science 2015;58(3):217-222
OBJECTIVE: To compare the laboratory outcomes of intracytoplasmic sperm injection (ICSI) and conventional insemination using sibling oocytes in poor prognosis IVF cycles where ICSI is not indicated. METHODS: Couples undergoing IVF with following conditions were enrolled: history of more than 3 years of unexplained infertility, history of > or =3 failed intrauterine insemination, leukocytospermia or wide variation in semen analysis, poor oocyte quality, or > or =50% of embryos had poor quality in previous IVF cycle(s). Couples with severe male factor requiring ICSI were excluded. Oocytes were randomly assigned to the conventional insemination (conventional group) or ICSI (ICSI group). Fertilization rate (FR), total fertilization failure, and embryonic development at day 3 and day 5 were assessed. RESULTS: A total of 309 mature oocytes from 37 IVF cycles (32 couples) were obtained: 161 were assigned to conventional group and 148 to ICSI group. FR was significantly higher in the ICSI group compared to the conventional group (90.5% vs. 72.7%, P<0.001). Total fertilization failure occurred in only one cycle in conventional group. On day 3, the percentage of cleavage stage embryos was higher in ICSI group however the difference was marginally significant (P=0.055). In 11 cycles in which day 5 culture was attempted, the percentage of blastocyst (per cleaved embryo) was significantly higher in the ICSI group than the conventional group (55.9% vs. 25.9%, P=0.029). CONCLUSION: Higher FR and more blastocyst could be achieved by ICSI in specific circumstances. Fertilization method can be tailored accordingly to improve IVF outcomes.
Blastocyst
;
Embryonic Development*
;
Embryonic Structures
;
Family Characteristics
;
Female
;
Fertilization
;
Fertilization in Vitro
;
Humans
;
Infertility
;
Insemination*
;
Male
;
Oocytes*
;
Pregnancy
;
Prognosis
;
Semen Analysis
;
Siblings
;
Sperm Injections, Intracytoplasmic
9.High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology
Tae Wook KONG ; Miseon KIM ; Young Han KIM ; Yong Beom KIM ; Jayeon KIM ; Jae Weon KIM ; Mi Hye PARK ; Joo Hyun PARK ; Jeong Ho RHEE ; Myong Cheol LIM ; Joon Seok HONG ;
Obstetrics & Gynecology Science 2020;63(2):107-107
Based on emerging data and current knowledge regarding high-risk human papillomavirus (hrHPV) testing as a primary screening for cervical cancer, the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology support the following scientific facts: • Compared to cytology, hrHPV screening has higher sensitivity and detects more cases of high-grade cervical intraepithelial neoplasia. • Qualified hrHPV testing can be considered as an alternative primary screening for cervical cancer to the current cytology method. • The starting age of primary hrHPV screening should not be before 25 years because of possible overtreatment in this age, which has a high human papillomavirus (HPV) prevalence but rarely progresses to cancer. The screening interval should be no sooner than every 3 years and no longer than every 5 years. • Before the introduction of hrHPV screening in Korea, research into comparative effectiveness of primary hrHPV screening for cervical cancer should be conducted to determine the appropriate HPV assay, starting age, and screening interval.
10.High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology
Tae Wook KONG ; Miseon KIM ; Young Han KIM ; Yong Beom KIM ; Jayeon KIM ; Jae Weon KIM ; Mi Hye PARK ; Joo Hyun PARK ; Jeong Ho RHEE ; Myong Cheol LIM ; Joon Seok HONG
Journal of Gynecologic Oncology 2020;31(1):31-